Preparation of alginate beads for floating drug delivery system

Effects of CO2 gas-forming agents

B. Y. Choi, Hyun Jin Park, S. J. Hwang, J. B. Park

Research output: Contribution to journalArticle

240 Citations (Scopus)

Abstract

Floating beads were prepared from a sodium alginate solution containing CaCO3 or NaHCO3 as gas-forming agents. The solution was dropped to 1% CaCl2 solution containing 10% acetic acid for CO2 gas and gel formation. The effects of gas-forming agents on bead size and floating properties were investigated. As gas-forming agents increased, the size and floating properties increased. Bead porosity and volume average pore size, as well as the surface and cross-sectional morphology of the beads were examined with Mercury porosimetry and Scanning Electron Microscopy. NaHCO3 significantly increased porosity and pore diameter than CaCO3. Incorporation of CaCO3 into alginate solution resulted in smoother beads than those produced with NaHCO3. Gel strength analysis indicated that bead strength decreased with increasing gas-forming agent from 9 to 4 N. Beads incorporating CaCO3 exhibited significantly increased gel strength over control and NaHCO3-containing samples. Release characteristics of riboflavin as a model drug were studied in vitro. Release rate of riboflavin increased proportionally with addition of NaHCO3. However, increasing weight ratios of CaCO3 did not appreciably accelerate drug release. The results of these studies indicate that CaCO3 is superior to NaHCO3 as a gas forming agent in alginate bead preparations. The enhanced buoyancy and sustained release properties of CaCO3-containing beads make them an excellent candidate for floating drug dosage systems (FDDS).

Original languageEnglish
Pages (from-to)81-91
Number of pages11
JournalInternational Journal of Pharmaceutics
Volume239
Issue number1-2
DOIs
Publication statusPublished - 2002 Jun 4

Fingerprint

Drug Delivery Systems
Gases
Riboflavin
Porosity
Gels
Mercury
Acetic Acid
Pharmaceutical Preparations
Electron Scanning Microscopy
alginic acid
Weights and Measures

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Preparation of alginate beads for floating drug delivery system : Effects of CO2 gas-forming agents. / Choi, B. Y.; Park, Hyun Jin; Hwang, S. J.; Park, J. B.

In: International Journal of Pharmaceutics, Vol. 239, No. 1-2, 04.06.2002, p. 81-91.

Research output: Contribution to journalArticle

@article{bd85dc08b4d6473ca500cd5cffde0683,
title = "Preparation of alginate beads for floating drug delivery system: Effects of CO2 gas-forming agents",
abstract = "Floating beads were prepared from a sodium alginate solution containing CaCO3 or NaHCO3 as gas-forming agents. The solution was dropped to 1{\%} CaCl2 solution containing 10{\%} acetic acid for CO2 gas and gel formation. The effects of gas-forming agents on bead size and floating properties were investigated. As gas-forming agents increased, the size and floating properties increased. Bead porosity and volume average pore size, as well as the surface and cross-sectional morphology of the beads were examined with Mercury porosimetry and Scanning Electron Microscopy. NaHCO3 significantly increased porosity and pore diameter than CaCO3. Incorporation of CaCO3 into alginate solution resulted in smoother beads than those produced with NaHCO3. Gel strength analysis indicated that bead strength decreased with increasing gas-forming agent from 9 to 4 N. Beads incorporating CaCO3 exhibited significantly increased gel strength over control and NaHCO3-containing samples. Release characteristics of riboflavin as a model drug were studied in vitro. Release rate of riboflavin increased proportionally with addition of NaHCO3. However, increasing weight ratios of CaCO3 did not appreciably accelerate drug release. The results of these studies indicate that CaCO3 is superior to NaHCO3 as a gas forming agent in alginate bead preparations. The enhanced buoyancy and sustained release properties of CaCO3-containing beads make them an excellent candidate for floating drug dosage systems (FDDS).",
keywords = "Alginate bead, CaCO, Floating bead, Floating drug dosage system (FDDS), Gas-forming agent, NaHCO",
author = "Choi, {B. Y.} and Park, {Hyun Jin} and Hwang, {S. J.} and Park, {J. B.}",
year = "2002",
month = "6",
day = "4",
doi = "10.1016/S0378-5173(02)00054-6",
language = "English",
volume = "239",
pages = "81--91",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Preparation of alginate beads for floating drug delivery system

T2 - Effects of CO2 gas-forming agents

AU - Choi, B. Y.

AU - Park, Hyun Jin

AU - Hwang, S. J.

AU - Park, J. B.

PY - 2002/6/4

Y1 - 2002/6/4

N2 - Floating beads were prepared from a sodium alginate solution containing CaCO3 or NaHCO3 as gas-forming agents. The solution was dropped to 1% CaCl2 solution containing 10% acetic acid for CO2 gas and gel formation. The effects of gas-forming agents on bead size and floating properties were investigated. As gas-forming agents increased, the size and floating properties increased. Bead porosity and volume average pore size, as well as the surface and cross-sectional morphology of the beads were examined with Mercury porosimetry and Scanning Electron Microscopy. NaHCO3 significantly increased porosity and pore diameter than CaCO3. Incorporation of CaCO3 into alginate solution resulted in smoother beads than those produced with NaHCO3. Gel strength analysis indicated that bead strength decreased with increasing gas-forming agent from 9 to 4 N. Beads incorporating CaCO3 exhibited significantly increased gel strength over control and NaHCO3-containing samples. Release characteristics of riboflavin as a model drug were studied in vitro. Release rate of riboflavin increased proportionally with addition of NaHCO3. However, increasing weight ratios of CaCO3 did not appreciably accelerate drug release. The results of these studies indicate that CaCO3 is superior to NaHCO3 as a gas forming agent in alginate bead preparations. The enhanced buoyancy and sustained release properties of CaCO3-containing beads make them an excellent candidate for floating drug dosage systems (FDDS).

AB - Floating beads were prepared from a sodium alginate solution containing CaCO3 or NaHCO3 as gas-forming agents. The solution was dropped to 1% CaCl2 solution containing 10% acetic acid for CO2 gas and gel formation. The effects of gas-forming agents on bead size and floating properties were investigated. As gas-forming agents increased, the size and floating properties increased. Bead porosity and volume average pore size, as well as the surface and cross-sectional morphology of the beads were examined with Mercury porosimetry and Scanning Electron Microscopy. NaHCO3 significantly increased porosity and pore diameter than CaCO3. Incorporation of CaCO3 into alginate solution resulted in smoother beads than those produced with NaHCO3. Gel strength analysis indicated that bead strength decreased with increasing gas-forming agent from 9 to 4 N. Beads incorporating CaCO3 exhibited significantly increased gel strength over control and NaHCO3-containing samples. Release characteristics of riboflavin as a model drug were studied in vitro. Release rate of riboflavin increased proportionally with addition of NaHCO3. However, increasing weight ratios of CaCO3 did not appreciably accelerate drug release. The results of these studies indicate that CaCO3 is superior to NaHCO3 as a gas forming agent in alginate bead preparations. The enhanced buoyancy and sustained release properties of CaCO3-containing beads make them an excellent candidate for floating drug dosage systems (FDDS).

KW - Alginate bead

KW - CaCO

KW - Floating bead

KW - Floating drug dosage system (FDDS)

KW - Gas-forming agent

KW - NaHCO

UR - http://www.scopus.com/inward/record.url?scp=0037018959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037018959&partnerID=8YFLogxK

U2 - 10.1016/S0378-5173(02)00054-6

DO - 10.1016/S0378-5173(02)00054-6

M3 - Article

VL - 239

SP - 81

EP - 91

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -